Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | PYXS | ELYM | PRLD | ||
Company | Pyxis Oncology Inc | Eliem Therapeutics Inc | Prelude Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 3.75 | 7.75 | 3.84 | ||
High | 3.87 | 8.30 | 3.94 | ||
Low | 3.71 | 7.56 | 3.59 | ||
Last | 3.74 | 7.71 | 3.85 | ||
Change | +0.02 | +0.05 | -0.02 | ||
% Change | +0.54% | +0.65% | -0.52% | ||
Volume | 246,100 | 68,700 | 85,000 | ||
20-Day Average Volume | 382,595 | 229,235 | 42,650 | ||
Previous Close | 3.72 | 7.66 | 3.87 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 4.10 | 8.31 | 3.90 | ||
20-Day Raw Stochastic | 14.05% | 15.14% | 48.18% | ||
20-Day Relative Strength | 38.70% | 58.32% | 47.57% | ||
Weighted Alpha | -29.37 | -11.74 | -35.98 | ||
Today's Opinion | 8% Buy | 88% Buy | 8% Buy | ||
Previous Opinion | 8% Buy | 88% Buy | 8% Buy | ||
Last Month's Opinion | 40% Buy | 100% Buy | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -2.09% since 05/23/24 | +3.63% since 05/23/24 | -4.70% since 05/23/24 | ||
Low | 3.57 on 05/28/24 | 7.03 on 05/24/24 | 3.32 on 05/29/24 | ||
High | 3.96 on 05/24/24 | 8.30 on 05/31/24 | 4.28 on 05/24/24 | ||
1-Month | |||||
%Chg | -15.96% since 04/30/24 | +8.74% since 04/30/24 | +2.12% since 04/30/24 | ||
Low | 3.57 on 05/28/24 | 6.66 on 05/01/24 | 3.32 on 05/29/24 | ||
High | 4.78 on 05/03/24 | 11.55 on 05/03/24 | 4.42 on 05/22/24 | ||
3-Month | |||||
%Chg | -41.19% since 02/29/24 | +182.42% since 02/29/24 | -10.47% since 02/29/24 | ||
Low | 3.57 on 05/28/24 | 2.52 on 04/05/24 | 3.32 on 05/29/24 | ||
High | 6.79 on 03/05/24 | 11.55 on 05/03/24 | 5.83 on 04/15/24 | ||
6-Month | |||||
%Chg | +140.51% since 11/29/23 | +200.00% since 11/29/23 | +14.58% since 11/29/23 | ||
Low | 1.56 on 11/30/23 | 2.35 on 12/11/23 | 2.62 on 02/09/24 | ||
High | 6.85 on 02/27/24 | 11.55 on 05/03/24 | 5.83 on 04/15/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 220,241 | 224,292 | 211,480 | ||
Shares Outstanding, K | 58,888 | 29,091 | 54,930 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -73,790,000 | -35,120,000 | -121,830,000 | ||
Last Quarter Sales | 16,150,000 | 0 | 0 | ||
Last Quarter Net Income | -3,260,000 | -1,700,000 | -31,430,000 | ||
60-Month Beta | 1.45 | -0.36 | 1.56 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.06 on 05/14/24 | -0.06 on 05/15/24 | -0.42 on 05/07/24 | ||
Latest Earnings Date | 05/16/24 | 05/16/24 | 05/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |